Israel Englander Biotechnology

Millennium Management LLC

  • $192 Billion
  • Q4 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
REGN
Regeneron Pharmaceuticals, Inc.
PUT
$42.2 Million
59.2K
Q4 2024
Reduced 33.64%
NVO
Novo Nordisk A S
CALL
$34.2 Million
398K
Q4 2024
Reduced 49.93%
VRTX
Vertex Pharmaceuticals Inc
PUT
$21.9 Million
54.5K
Q4 2024
Added 95.01%
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$18.6 Million
26.1K
Q4 2024
Reduced 33.64%
VRTX
Vertex Pharmaceuticals Inc
CALL
$15.3 Million
38.1K
Q4 2024
Added 95.01%
MRNA
Moderna, Inc.
PUT
$12.8 Million
307K
Q4 2024
Added 650.99%
AXSM
Axsome Therapeutics, Inc.
PUT
$10.1 Million
119K
Q4 2024
Reduced 82.85%
CORT
Corcept Therapeutics Inc
CALL
$7.14 Million
142K
Q4 2024
Added 112.5%
VKTX
Viking Therapeutics, Inc.
CALL
$6.58 Million
163K
Q4 2024
Reduced 40.38%
MRNA
Moderna, Inc.
CALL
$6.05 Million
146K
Q4 2024
Added 650.99%
VCEL
Vericel Corp
PUT
$4.22 Million
76.8K
Q4 2024
Added 93.25%
VCYT
Veracyte, Inc.
CALL
$3.96 Million
100K
Q4 2024
Reduced 28.4%
CORT
Corcept Therapeutics Inc
PUT
$3.53 Million
70K
Q4 2024
Added 112.5%
EXEL
Exelixis, Inc.
PUT
$3.47 Million
104K
Q4 2024
Added 82.26%
NVO
Novo Nordisk A S
PUT
$3.45 Million
40.1K
Q4 2024
Reduced 49.93%
RPRX
Royalty Pharma PLC
CALL
$3.41 Million
134K
Q4 2024
Reduced 44.37%
INCY
Incyte Corp
CALL
$3.19 Million
46.2K
Q4 2024
Reduced 3.4%
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$3.13 Million
13.3K
Q4 2024
Added 32.87%
GMAB
Genmab A/S
CALL
$2.67 Million
128K
Q4 2024
Added 64.25%
BMRN
Biomarin Pharmaceutical Inc
CALL
$2.66 Million
40.5K
Q4 2024
Reduced 36.49%
SRPT
Sarepta Therapeutics, Inc.
PUT
$2.58 Million
21.2K
Q4 2024
Reduced 41.11%
ADMA
Adma Biologics, Inc.
CALL
$2.57 Million
150K
Q4 2024
Added 3.81%
JAZZ
Jazz Pharmaceuticals PLC
CALL
$2.49 Million
20.2K
Q4 2024
Reduced 6.24%
KRYS
Krystal Biotech, Inc.
CALL
$2.38 Million
15.2K
Q4 2024
Reduced 60.2%
APLS
Apellis Pharmaceuticals, Inc.
CALL
$2.28 Million
71.3K
Q4 2024
Added 643.66%
BPMC
Blueprint Medicines Corp
CALL
$2.18 Million
25K
Q4 2024
Added 19.16%
ARVN
Arvinas, Inc.
CALL
$2.11 Million
110K
Q4 2024
Added 50.91%
BNTX
Bio N Tech Se
PUT
$1.9 Million
16.7K
Q4 2024
Added 610.98%
PTGX
Protagonist Therapeutics, Inc
CALL
$1.35 Million
35K
Q2 2024
Added 2135.58%
UTHR
United Therapeutics Corp
PUT
$1.16 Million
3.3K
Q4 2024
Added 210.18%
AXSM
Axsome Therapeutics, Inc.
CALL
$1.07 Million
12.7K
Q4 2024
Reduced 82.85%
CRVS
Corvus Pharmaceuticals, Inc.
CALL
$942,000
181K
Q4 2024
Reduced 50.24%
VRNA
Verona Pharma PLC
CALL
$928,000
20K
Q4 2024
Added 7.15%
SWTX
Spring Works Therapeutics, Inc.
CALL
$906,000
25.1K
Q3 2024
Added 413.88%
RVMD
Revolution Medicines, Inc.
CALL
$874,000
20K
Q1 2024
New holding
SRPT
Sarepta Therapeutics, Inc.
CALL
$851,000
7K
Q4 2024
Reduced 41.11%
COGT
Cogent Biosciences, Inc.
CALL
$780,000
100K
Q4 2024
Reduced 96.5%
KRYS
Krystal Biotech, Inc.
PUT
$751,000
4.8K
Q4 2024
Reduced 60.2%
ATXS
Astria Therapeutics, Inc.
CALL
$616,000
70K
Q4 2024
Reduced 22.59%
CYTK
Cytokinetics Inc
CALL
$555,000
11.8K
Q4 2024
Reduced 16.63%
IMVT
Immunovant, Inc.
CALL
$550,000
20K
Q4 2024
Reduced 60.93%
BMRN
Biomarin Pharmaceutical Inc
PUT
$545,000
8.3K
Q4 2024
Reduced 36.49%
MLTX
Moon Lake Immunotherapeutics
CALL
$531,000
10K
Q3 2024
Reduced 76.37%
MDGL
Madrigal Pharmaceuticals, Inc.
PUT
$524,000
1.7K
Q4 2024
Reduced 85.29%
INSM
Insmed Inc
PUT
$517,000
7.5K
Q4 2024
Added 23.75%
VKTX
Viking Therapeutics, Inc.
PUT
$382,000
9.5K
Q4 2024
Reduced 40.38%
SGMO
Sangamo Therapeutics, Inc
CALL
$335,000
329K
Q4 2024
Added 43.34%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$329,000
1.4K
Q4 2024
Added 32.87%
EWTX
Edgewise Therapeutics, Inc.
CALL
$267,000
10K
Q4 2024
Reduced 9.94%
Filter Shares Options
Israel Englander

Israel Englander

Israel Englander is the founder and CEO of Millennium Management, a successful investment firm that uses technology and data-driven approaches to investing. Englander is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Israel Englander's portfolio
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email